Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 200 participants.

Also called NCT05560204

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Prince of Wales Hospital, Shatin, Hong Kong (from the registry)
Registry
  • NCT NCT05560204
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Hong Kong SAR China (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05560204. Randomized; no masking; primary purpose treatment. Start 2023-01-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet
Acronym
COMPAWA
Condition
Combined Pulsed-field Ablation (PFA)
Intervention (Device)
Combined Pulsed-field Ablation (PFA) + Left Atrial Appendage Occlusion (LAAO)
Lead sponsor
Prince of Wales Hospital, Shatin, Hong Kong (class: other)

Record details

Record id
cardio:ct-nct05560204
Content hash
ed19d73322c06a736a6eb1a1749871e5175a9c8587c76da3337402e0f12568b6